Do optimal vascular and inflammatory biomarkers indicate low current evidence of injury?

At age 52, this biomarker pattern is broadly reassuring for the specific processes each test measures at the time of sampling, but it is not a comprehensive exclusion of vascular, endothelial, oxidative, inflammatory, or renal microvascular pathology.

Oxidative and inflammatory biology

• F2-isoprostanes provide the strongest support: these are products of free-radical, nonenzymatic arachidonic-acid peroxidation. An assay-appropriately optimal urinary or plasma result supports low current evidence of in-vivo oxidative lipid injury. Interpretation remains specimen- and method-dependent; chemical mass-spectrometric methods are preferable.
• hs-CRP supports low current biochemical evidence of IL-6–driven systemic acute-phase inflammation when measured during clinical stability. A value <1 mg/L is conventionally a low cardiovascular-risk category, but not a diagnostic exclusion threshold. Within-person variability is substantial (coefficient of variation 46.2% in one cohort); two measurements at least 2 weeks apart better establish baseline status.
• Low oxidized LDL plausibly reflects a lower circulating burden of the oxidation epitope measured by that assay, not necessarily lower oxidation within the arterial wall.

Vascular and endothelial interpretation

• Low MPO and Lp-PLA₂ activity are directionally compatible with less activity in selected plaque-related oxidative-inflammatory pathways. MPO generates oxidants that modify LDL and impair endothelium; Lp-PLA₂ hydrolysis products can promote endothelial activation and macrophage recruitment. Neither has a validated “optimal” threshold that establishes low current vascular inflammation.
• Low ADMA is compatible with less competitive nitric-oxide-synthase inhibition. Higher ADMA has been associated with lower flow-mediated dilation and a cardiovascular-disease relative risk of 1.42 for highest versus lowest tertile, but low ADMA does not establish intact endothelial function from all causes.

Renal microvascular signal

• A UACR <30 mg/g (<3 mg/mmol; KDIGO A1) indicates normal-to-mildly increased albumin excretion and is reassuring against currently detectable albuminuric glomerular injury, while remaining a continuous risk marker.

Bottom line

• Collectively, optimal results indicate low current measured evidence of several relevant pathways—most directly systemic inflammation and lipid peroxidation—but should complement, rather than replace, established cardiovascular and kidney risk assessment.